Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of prostatitis.

H S Gurunadha Rao Tunuguntla1, C P Evans

  • 1Department of Urology, University of California Davis School of Medicine and UC Davis Medical Center, Sacramento, California 95817, USA.

Prostate Cancer and Prostatic Diseases
|December 24, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and operation of the defence COVID-19 lab as a SARS-CoV-2 diagnostic screening capability for UK military personnel.

BMJ military health·2022
Same author

Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor.

Cell death & disease·2014
Same author

Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model.

Oncogene·2014
Same author

miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.

Oncogene·2013
Same author

Decreased prostate cancer cell migration by inhibition of the insulin-like growth factor II/Mannose-6-Phosphate receptor.

Urologic oncology·2011
Same journal

Focal therapy for localized prostate cancer: not all that glitters is gold.

Prostate cancer and prostatic diseases·2026
Same journal

A nationwide histopathology study reflecting the impact of the introduction of MRI in the diagnostic trajectory of prostate cancer in routine clinical care.

Prostate cancer and prostatic diseases·2026
Same journal

En-bloc vs lobe-by-lobe laser prostatectomy: where do we stand?

Prostate cancer and prostatic diseases·2026
Same journal

Response to de Riese et al. regarding "methodological and clinical considerations of MRI-based prostate cancer risk calculators".

Prostate cancer and prostatic diseases·2026
Same journal

Methodological and clinical considerations of MRI-based prostate cancer risk calculators.

Prostate cancer and prostatic diseases·2026
Same journal

Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial.

Prostate cancer and prostatic diseases·2026
See all related articles

Prostatitis affects 5-9% of men, causing millions of US hospital visits. This review covers its causes, classification, evaluation, and treatments like microwave hyperthermia for prostatitis syndromes.

Area of Science:

  • Urology
  • Andrology
  • Internal Medicine

Background:

  • Prostatitis is a prevalent condition affecting 5-9% of men.
  • It accounts for over 2 million annual hospital visits in the USA.
  • Traditional classification includes acute bacterial, chronic bacterial, abacterial prostatitis, and prostatodynia.

Purpose of the Study:

  • To present contemporary knowledge on prostatitis etiology, classification, evaluation, and treatment.
  • To review the impact of the 2000 US National Institute of Diabetes and Digestive and Kidney Diseases consensus conference.
  • To discuss novel treatment modalities for prostatitis syndromes.

Main Methods:

  • Literature review of contemporary knowledge and experience.
  • Analysis of classification systems for prostatitis.

Related Experiment Videos

  • Evaluation of treatment options, including transurethral microwave hyperthermia and transurethral needle ablation.

    • Main Results:

    • Prostatitis remains a common and complex clinical entity.
    • Renewed interest in prostatitis syndromes following the 2000 consensus conference.
    • Transurethral microwave hyperthermia and transurethral needle ablation are discussed as treatment options.

    Conclusions:

    • Understanding the etiology, classification, and evaluation of prostatitis is crucial.
    • Contemporary treatment strategies for prostatitis syndromes are evolving.
    • Further research is needed to optimize management of prostatitis.